Markets:

Overview

News

Currencies

International

Treasuries

Prothena Corporation plc - Ordinary Shares (NQ:PRTA)

10.18 +10.18 (+1131011.11%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Prothena Corporation plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

4 Analysts Have This to Say About Prothena Corp ↗

December 18, 2023

Via Benzinga

Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others ↗

November 21, 2023

Recent advancements in Alzheimer's disease treatments targeting the removal of toxic proteins (white matter) from the brain have sparked a renewed interest in developing vaccines to combat this

Via Benzinga

Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning ↗

November 17, 2023

Biotech companies are edging closer to finding the answers behind Alzheimer's disease.

Via Investor's Business Daily

8 Health Care Stocks Whale Activity In Today's Session ↗

November 07, 2023

Via Benzinga

Prothena Reports Third Quarter 2023 Financial Results and Business Highlights

November 02, 2023

From Prothena Corporation plc

Via Business Wire

Earnings Preview For Prothena Corp ↗

November 01, 2023

Via Benzinga

Expert Ratings for Prothena Corp ↗

October 23, 2023

Via Benzinga

Expert Ratings for Prothena Corp ↗

August 22, 2023

Via Benzinga

Prothena to Report Third Quarter 2023 Financial Results on November 2

October 26, 2023

From Prothena Corporation plc

Via Business Wire

Biogen Pulls Prothena Into A Steep Dive On Mixed Results For Alzheimer's Treatment ↗

October 26, 2023

Both companies are working on under-the-skin injections for Alzheimer's treatment.

Via Investor's Business Daily

Lululemon, PCTEL, Consolidated Communications, Other Stocks Jumping Higher On Monday ↗

October 16, 2023

U.S. stocks traded higher, with the Dow Jones gaining more than 350 points on Monday. Here are some stocks recording big gains in today’s session.

Via Benzinga

Topics Stocks

JMP Securities Maintains Outperform Rating for Prothena Corp: Here's What You Need To Know ↗

August 04, 2023

Via Benzinga

Earnings Scheduled For August 3, 2023 ↗

August 03, 2023

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.

Via Benzinga

Prothena Corp's Earnings Outlook ↗

August 02, 2023

Via Benzinga

Expert Ratings for Prothena Corp ↗

July 11, 2023

Via Benzinga

8 Analysts Have This to Say About Prothena Corp ↗

June 21, 2023

Via Benzinga

Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

October 16, 2023

Gainers MingZhu Logistics Holdings Limited (NASDAQ: YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.

Via Benzinga

Why Is Alzheimer's Player Prothena Stock Trading Higher Today? ↗

October 16, 2023

Prothena Corporation plc (NASDAQ: PRTA) is reportedly talking to advisors, potentially preparing for a sale.

Via Benzinga

Looking Into Prothena Corp's Return On Capital Employed ↗

May 16, 2023

Via Benzinga

Recap: Prothena Corp Q1 Earnings ↗

May 04, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

October 05, 2023

On Thursday, 369 companies hit new 52-week lows.

Via Benzinga

Prothena to Participate in Upcoming Healthcare Conferences

August 31, 2023

From Prothena Corporation plc

Via Business Wire

Prothena Reports Second Quarter 2023 Financial Results and Business Highlights

August 03, 2023

From Prothena Corporation plc

Via Business Wire

Prothena to Report Second Quarter 2023 Financial Results on August 3

July 27, 2023

From Prothena Corporation plc

Via Business Wire

Prothena Presents New Research in the Treatment of Alzheimer’s Disease at Alzheimer’s Association International Conference® 2023 (AAIC®)

July 17, 2023

From Prothena Corporation plc

Via Business Wire

Prothena to Present New Data from Alzheimer’s Disease Programs at Alzheimer’s Association International Conference® 2023 (AAIC®)

July 11, 2023

From Prothena Corporation plc

Via Business Wire

Prothena Announces Bristol Myers Squibb Opt-in for Worldwide Rights of PRX005, a Novel Anti-MTBR-Tau Antibody

July 10, 2023

From Prothena Corporation plc

Via Business Wire

Prothena Announces Phase 3 VITAL Clinical Trial Results Published in Blood Showing Survival Benefit in Patients with Mayo Stage IV AL Amyloidosis Treated with Birtamimab

June 27, 2023

From Prothena Corporation plc

Via Business Wire

Prothena to Participate in Jefferies 2023 Healthcare Conference

June 02, 2023

From Prothena Corporation plc

Via Business Wire

Prothena Announces Appointment of Billy Dunn, M.D., to its Board of Directors

May 16, 2023

From Prothena Corporation plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.